✦ LIBER ✦

How to avoid discontinuation of ribavirin in combination with interferon to maintain efficacy of treatment for chronic hepatitis C patients

✍ Scribed by Akinori Kasahara

Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 106 KB
Volume: 39
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-004-1484-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of re-treatment with pegylated

Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

✍ Tsugiko Oze; Naoki Hiramatsu; Takayuki Yakushijin; Kiyoshi Mochizuki; Masahide O 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 297 KB

Retreatment of patients with chronic hep

Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine

✍ Rudolf E Stauber; Harald Hofer; Franz Hackl; Kurt Schüze; Christian Datz; Karin 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 738 KB

Treatment of chronic hepatitis C patient

Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon α — hype or hope?

✍ Wolfgang Vogel 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 440 KB

Immunological predictors of different re

Immunological predictors of different responses to combination therapy with interferon α and ribavirin in patients with chronic hepatitis C

✍ Ravdan Amaraa; Helena Mareckova; Petr Urbanek; Terezie Fucikova 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 215 KB

Interferon alfa-2b in combination with r

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics

✍ Regino P. González-Peralta; Deirdre A. Kelly; Barbara Haber; Jean Molleston; Kar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Chronic hepatitis C virus (HCV) infection is usually asymptomatic in children, but significant liver disease may occur. We evaluated the efficacy, safety, and pharmacokinetics of interferon alfa-2b and ribavirin in children with chronic HCV. We determined the optimal ribavirin dose in an initial coh

Adequate timing of ribavirin reduction i

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Ma 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 171 KB